Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone

NCT01739335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

FED

Sponsor class

Conditions

Stress Disorders, Post-Traumatic

Interventions

DRUG: Mifepristone Oral Tablet [Korlym]
DRUG: Placebo Oral Tablet

Sponsor

VA Office of Research and Development